Clinical Trial

The Role of the Human Microbiome in Patients After Pancreatic Resection.

Study acronym: MiPac
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated April 27, 2026 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to classify patients that undergo pancreatic resection for presumed pancreatic or periampullary malignancy into high and low risk groups for postoperative complications based on longitudinal saliva, rectal/faecal, tumor, blood and/or bile microbiome profiles. To identify the dynamics of the microbiome, as well as the possibly related short-term and long-term complications, multiple samples at different timepoints are needed from the patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-04-19.
Status change: Not Yet Recruiting → Enrolling by Invitation 2026-04-22
Trial Details
NCT Number NCT06381882
Lead Sponsor St. Antonius Hospital
Conditions Pancreas Cancer, Pancreas Neoplasm, Pancreas Adenocarcinoma, Periampullary Cancer, Periampullary Carcinoma, Microbial Colonization
Enrollment 200 participants
Start Date 2024-06-01
Primary Completion 2026-08-01 (estimated)
Study Completion 2026-11-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-27